Virtu Financial LLC Kala Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.25 - $11.7 $2,440 - $114,227	-9,763 Reduced 13.08%	64,873 $14,000
Q2 2022 Aug 09, 2022	SELL	$0.3 - $1.31 $19,762 - $86,296	-65,875 Reduced 46.88%	74,636 $22,000
Q1 2022 May 17, 2022	BUY	$0.61 - $1.84 $8,710 - $26,275	14,280 Added 11.31%	140,511 $194,000
Q4 2021 Feb 17, 2022	BUY	$1.16 - $2.74 $146,427 - $345,872	126,231 New	126,231 $153,000
Q3 2020 Dec 11, 2020	SELL	$7.5 - $11.11 $96,120 - $142,385	-12,816 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$8.33 - $13.79 $88,997 - $147,332	-10,684 Reduced 45.46%	12,816 $135,000
Q4 2019 Feb 04, 2020	BUY	$3.36 - $4.81 $78,960 - $113,034	23,500 New	23,500 $87,000
Q4 2018 Jan 16, 2019	SELL	$4.29 - $9.94 $87,129 - $201,881	-20,310 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$9.54 - $13.87 $193,757 - $281,699	20,310 New	20,310 $200,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.83M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.